Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02663362
NCT02663362
Recruiting
Not Applicable

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

AdventHealth Translational Research Institute1 site in 1 country250 target enrollmentFebruary 1, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHuman Body CompositionHuman Body Function

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human Body Composition
Sponsor
AdventHealth Translational Research Institute
Enrollment
250
Locations
1
Primary Endpoint
Whole body fat quantification
Status
Recruiting
Last Updated
last month
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body

Registry
clinicaltrials.gov
Start Date
February 1, 2012
End Date
January 1, 2027
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Sponsor
AdventHealth Translational Research Institute
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Male or female
  • •Age 12 - 89
  • •Healthy (self assessed)
  • •Weight under 350lbs
  • •Able to walk 50 yards without stopping
  • •Able to travel to hospital for study visits
  • •Able to follow a 3-step command
  • •Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours

Exclusion Criteria

  • •Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings.
  • •Are unwilling or unable to complete the imaging procedures for the duration of the MRI scan due to claustrophobia or other reason.
  • •Serious mental illness that might preclude subject's ability to comply with study treatment
  • •Life expectancy of less than 1 year
  • •Are pregnant or plan on becoming pregnant in the next 8 weeks.

Outcomes

Primary Outcomes

Whole body fat quantification

Time Frame: 1 hour

Secondary Outcomes

  • Fat Microstructure(1 hour)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Magnetic Resonance & Optical Spectroscopy ValidationValidation StudiesMagnetic Resonance Spectroscopy
NCT01827527AdventHealth Translational Research Institute31
Completed
Not Applicable
The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone LossMyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
NCT03951220Oxford University Hospitals NHS Trust67
Recruiting
Not Applicable
Quantitative MRI Assessment of Breast Cancer Therapy ResponseBreast Cancer
NCT05704062Corewell Health East135
Recruiting
Not Applicable
Development and validation of magnet resonance elastography of the aorta for assessment of the central cardiovascular systemI10-I15I70-I79Hypertensive diseasesDiseases of arteries, arterioles and capillaries
DRKS00013598Klinik und Hochschulambulanz für Radiologie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin200
Completed
Not Applicable
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral SclerosisPrimary Lateral SclerosisHereditary Spastic ParaplegiaAmyotrophic Lateral Sclerosis
NCT00023075National Institute of Neurological Disorders and Stroke (NINDS)55